CDKN2A and neoplasm: Methylated p14ARF was significantly associated with tumor histology, and it was lower in ccRCC than in non-ccRCC, suggesting that p14ARF promoter methylation had a decreased risk of ccRCC; whereas methylated p16INK4A had a similar frequency in ccRCC and Non-ccRCC.